Biocryst Pharmaceuticals Inc (BCRX) Implied Volatility Current

Tracking BCRX implied volatility helps you identify when options premiums on Biocryst Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Biocryst Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when BCRX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Biocryst Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BCRX, tracking metrics like BCRX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BCRX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika.

The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BCRX implied volatility sits today versus where it has been. Our scanner ranks Biocryst Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in BCRX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Biocryst Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.